315 related articles for article (PubMed ID: 23624585)
1. Human papillomavirus vaccine and systemic lupus erythematosus.
Gatto M; Agmon-Levin N; Soriano A; Manna R; Maoz-Segal R; Kivity S; Doria A; Shoenfeld Y
Clin Rheumatol; 2013 Sep; 32(9):1301-7. PubMed ID: 23624585
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus following HPV immunization or infection?
Soldevilla HF; Briones SF; Navarra SV
Lupus; 2012 Feb; 21(2):158-61. PubMed ID: 22235047
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of HPV vaccination in women with systemic lupus erythematosus (SLE).
Infante V; Miyaji KT; Soarez PC; Sartori AMC
Expert Rev Vaccines; 2021 Mar; 20(3):309-318. PubMed ID: 33573404
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.
Mok CC; Ho LY; Fong LS; To CH
Ann Rheum Dis; 2013 May; 72(5):659-64. PubMed ID: 22589375
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Grimaldi-Bensouda L; Guillemot D; Godeau B; Bénichou J; Lebrun-Frenay C; Papeix C; Labauge P; Berquin P; Penfornis A; Benhamou PY; Nicolino M; Simon A; Viallard JF; Costedoat-Chalumeau N; Courcoux MF; Pondarré C; Hilliquin P; Chatelus E; Foltz V; Guillaume S; Rossignol M; Abenhaim L;
J Intern Med; 2014 Apr; 275(4):398-408. PubMed ID: 24206418
[TBL] [Abstract][Full Text] [Related]
6. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.
Geier DA; Geier MR
Immunol Res; 2017 Feb; 65(1):46-54. PubMed ID: 27406735
[TBL] [Abstract][Full Text] [Related]
7. [A case of systemic lupus erythematosus (SLE) following Human papillomavirus (HPV) vaccination].
Ito H; Noda K; Hirai K; Ukichi T; Furuya K; Kurosaka D
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):145-9. PubMed ID: 27212601
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus following human papillomavirus vaccination: A case-based review.
He N; Leng X; Zeng X
Int J Rheum Dis; 2022 Oct; 25(10):1208-1212. PubMed ID: 35948863
[TBL] [Abstract][Full Text] [Related]
9. Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus.
Mok CC; Ho LY; To CH
Vaccine; 2018 May; 36(23):3301-3307. PubMed ID: 29699792
[TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.
Colafrancesco S; Perricone C; Tomljenovic L; Shoenfeld Y
Am J Reprod Immunol; 2013 Oct; 70(4):309-16. PubMed ID: 23902317
[TBL] [Abstract][Full Text] [Related]
11. The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus.
Dhar JP; Essenmacher L; Dhar R; Magee A; Ager J; Sokol RJ
Vaccine; 2017 May; 35(20):2642-2646. PubMed ID: 28404357
[TBL] [Abstract][Full Text] [Related]
12. HPV vaccines and lupus: current approaches towards preventing adverse immune cross-reactivity.
Bragazzi NL; Bridgewood C; Sharif K; Kamal M; Amital H; Watad A; Shoenfeld Y
Expert Rev Vaccines; 2019 Jan; 18(1):31-42. PubMed ID: 30526148
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study.
Rotstein Grein IH; Pinto NF; Lobo A; Groot N; Sztajnbok F; da Silva CAA; Paim Marques LB; Appenzeller S; Islabão AG; Magalhães CS; de Almeida RG; Bica B; Fraga M; da Fraga ACM; Dos Santos MC; Robazzi T; Terreri MTR; Bandeira M; Pasmans H; Schepp R; van der Klis F; de Roock S; Wulffraat N; Pileggi G
Lupus; 2020 Jul; 29(8):934-942. PubMed ID: 32501172
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.
Zafrir Y; Agmon-Levin N; Paz Z; Shilton T; Shoenfeld Y
Lupus; 2012 Feb; 21(2):146-52. PubMed ID: 22235045
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease.
Itani MH; Uthman I
Lupus; 2012 Oct; 21(12):1370-1. PubMed ID: 22813547
[No Abstract] [Full Text] [Related]
16. Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine.
Anaya JM; Reyes B; Perdomo-Arciniegas AM; Camacho-Rodríguez B; Rojas-Villarraga A
Clin Exp Rheumatol; 2015; 33(4):545-8. PubMed ID: 25962455
[TBL] [Abstract][Full Text] [Related]
17. HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know.
Grein IH; Groot N; Lacerda MI; Wulffraat N; Pileggi G
Pediatr Rheumatol Online J; 2016 Mar; 14(1):12. PubMed ID: 26956735
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events.
Geier DA; Geier MR
Clin Rheumatol; 2015 Jul; 34(7):1225-31. PubMed ID: 25535199
[TBL] [Abstract][Full Text] [Related]
19. Lupus and vaccinations.
Mathian A; Pha M; Amoura Z
Curr Opin Rheumatol; 2018 Sep; 30(5):465-470. PubMed ID: 29889693
[TBL] [Abstract][Full Text] [Related]
20. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
